buyWeak cluster of 410b5-1 plan
Jones James bought $1,318 of CPIX
director at CUMBERLAND PHARMACEUTICALS INC. 769 shares at an average of $1.71, traded Dec 2, 2024, filed Dec 30, 2024.
Conviction score
20Value
$1,318
769 shares
Holdings after
40,146
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-052608, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | POpen-market purchase Common Stock10b5-1 | +70 | $1.33 | $93 | 39,447 | Dec 30, 2024 |
| Dec 3, 2024 | POpen-market purchase Common Stock10b5-1 | +70 | $1.26 | $88 | 39,517 | Dec 30, 2024 |
| Dec 4, 2024 | POpen-market purchase Common Stock10b5-1 | +70 | $1.22 | $85 | 39,587 | Dec 30, 2024 |
| Dec 5, 2024 | POpen-market purchase Common Stock10b5-1 | +65 | $1.20 | $78 | 39,652 | Dec 30, 2024 |
| Dec 6, 2024 | POpen-market purchase Common Stock10b5-1 | +70 | $1.20 | $84 | 39,722 | Dec 30, 2024 |
| Dec 9, 2024 | POpen-market purchase Common Stock10b5-1 | +70 | $1.25 | $88 | 39,792 | Dec 30, 2024 |
| Dec 10, 2024 | POpen-market purchase Common Stock10b5-1 | +32 | $2.48 | $79 | 39,824 | Dec 30, 2024 |
| Dec 11, 2024 | POpen-market purchase Common Stock10b5-1 | +32 | $2.29 | $73 | 39,856 | Dec 30, 2024 |
| Dec 12, 2024 | POpen-market purchase Common Stock10b5-1 | +32 | $2.19 | $70 | 39,888 | Dec 30, 2024 |
| Dec 13, 2024 | POpen-market purchase Common Stock10b5-1 | +32 | $2.33 | $75 | 39,920 | Dec 30, 2024 |
| Dec 16, 2024 | POpen-market purchase Common Stock10b5-1 | +49 | $2.21 | $108 | 39,969 | Dec 30, 2024 |
| Dec 17, 2024 | POpen-market purchase Common Stock10b5-1 | +49 | $2.12 | $104 | 40,018 | Dec 30, 2024 |
| Dec 18, 2024 | POpen-market purchase Common Stock10b5-1 | +49 | $2.19 | $107 | 40,067 | Dec 30, 2024 |
| Dec 19, 2024 | POpen-market purchase Common Stock10b5-1 | +40 | $2.33 | $93 | 40,107 | Dec 30, 2024 |
| Dec 20, 2024 | POpen-market purchase Common Stock10b5-1 | +39 | $2.35 | $92 | 40,146 | Dec 30, 2024 |
Related signals
Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth director | $8,209 | 4,716 | |
| 25Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,318 | 769 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Young Caroline director | $256 | 154 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth director | $9,348 | 8,029 | |
| 25Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,755 | 1,506 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Jones James director | $1,755 | 1,506 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Young Caroline director | $755 | 647 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth director | $9,106 | 7,107 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J Chairman and CEO | $1,827 | 1,426 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Jones James director | $1,827 | 1,426 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.